Abstract
A clinical study was carried out on imipenem/cilastatin sodium (IPM/CS) in the perinatal period, and the results obtained are summarized as follows.
IPM/CS was given to 5 cases with puerperal intrauterine infection and 2 with puerperal fever.
The clinical efficacies were evaluated as good in 6 cases and poor in 1. The clinical efficacy rate was 85.7%.
In a bacteriological examination, 9 strains were isolated from 6 cases, and 7 strains were eradicated with an eradication rate of 77.8%.
No side effects were observed in any of the cases treated with IPM/CS.
